The Vanguard Group 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 6:01 pm Unchanged | 2024-09-30 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 17,292,092 4.650% | 0 (Unchanged) | Filing |
| 2024-11-04 1:59 pm Purchase | 2024-09-30 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 17,292,092 4.650% | 13,158,153 (+318.30%) | Filing |
| 2024-02-13 5:14 pm Purchase | 2023-12-29 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 4,133,939 5.210% | 177,971 (+4.50%) | Filing |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 3,955,968 4.990% | 88,297 (+2.28%) | Filing |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 3,867,671 5.060% | 391,361 (+11.26%) | Filing |
| 2021-02-10 10:52 am Sale | 2020-12-31 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 3,476,310 4.690% | -933,466 (-21.17%) | Filing |
| 2020-02-11 4:40 pm Purchase | 2019-12-31 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 4,409,776 6.330% | 4,409,776 (New Position) | Filing |